2010 CVM News: Unique collaboration holds potential for life-saving drugs for tuberculosis
Loading...
No Access Until
Permanent Link(s)
Other Titles
Author(s)
Abstract
This news item is about: Dr. David Russell, of Cornell’s College of Veterinary Medicine, has established a paradigm-shifting collaborative relationship with Vertex Pharmaceuticals, of Cambridge, Mass., opening a door for novel tuberculosis (TB) drug discovery. Dr. Russell’s long-term goal is to help the many millions around the world who suffer from tuberculosis, the disease caused by Mycobacterium tuberculosis, by finding new compounds that can reduce the treatment time and also be effective against drug resistant TB. The collaboration will provide access to the pharmaceutical company’s drug library, comprised of hundreds of thousands of compounds. Many of these compounds have not yet been screened for anti-tuberculosis activity.
Journal / Series
Volume & Issue
Description
Sponsorship
Date Issued
2010-10-07
Publisher
Cornell University, College of Veterinary Medicine
Keywords
Cornell University. College of Veterinary Medicine -- Periodicals.; Russell, David G.
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Rights URI
Types
article